Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Uncategorized

Moderna Considers Manufacturing Covid-19 Vaccines in Japan

-Nikkei https://asia.nikkei.com/Spotlight/Coronavirus/COVID-vaccines/Moderna-eyes-producing-COVID-vaccine-in-Asia-CEO-says

byCharles Gross

May 21, 2021

1 minute read

-Nikkei

https://asia.nikkei.com/Spotlight/Coronavirus/COVID-vaccines/Moderna-eyes-producing-COVID-vaccine-in-Asia-CEO-says

Arista Networks Q2 EPS $1.08 Beats $0.91 Estimate, Sales $1.05B Beat $975.92M Estimate

By Benzinga Newsdesk

Today, 4:35 AM

Arista Networks (NYSE:ANET) reported quarterly earnings of $1.08 per share which beat the analyst consensus estimate of $0.91 by 18.68 percent. This is a 58.82 percent increase over earnings of $0.68 per share from the

ANET

NATO Foreign Ministers To Hold Emergency Meeting Friday

By Benzinga Newsdesk

Today, 4:35 AM

-Bloomberg

RSX

Why Rite Aid Shares Are Soaring Today

By Vandana Singh

Today, 4:35 AM

Rite Aid Corp (NYSE:RAD) has reported Q4 FY22 sales of 6.06 billion, +2.5% Y/Y, beating the consensus of $5.95 billion.…

RAD

RBC Capital Maintains Sector Perform on Clorox, Lowers Price Target to $176

By Benzinga Newsdesk

Today, 4:35 AM

RBC Capital analyst Nik Modi maintains Clorox (NYSE:CLX) with a Sector Perform and lowers the price target from $200 to $176.

CLX

Moderna Considers Manufacturing Covid-19 Vaccines in Japan

Related Posts

Arista Networks Q2 EPS $1.08 Beats $0.91 Estimate, Sales $1.05B Beat $975.92M Estimate

NATO Foreign Ministers To Hold Emergency Meeting Friday

Why Rite Aid Shares Are Soaring Today

RBC Capital Maintains Sector Perform on Clorox, Lowers Price Target to $176